5851 - 5875 of 9033 Results
Title
Year
-
OPENTitle: Cellular localization of p-tau217 in brain and its association with p-tau217 plasma levelsJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page: 3End Page: 3Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40478-021-01307-2Best OA location URL: https://actaneurocomms.biomedcentral.com/counter/pdf/10.1186/s40478-021-01307-2Citation Count: 62
- Expert comment: “A case of missing pathology in a patient with LRRK2 Parkinson's disease”2019RESTRICTEDTitle: Expert comment: “A case of missing pathology in a patient with LRRK2 Parkinson's disease”Journal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 74Issue #:Start Page: 78End Page: 79Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.11.005Citation Count: 3
-
OPENTitle: Activation of endogenous PRKN by structural derepression is linked to increased turnover of the E3 ubiquitin ligaseJournal Name: AutophagyPublisher: Informa UK LimitedVol: 21Issue #: 12Start Page: 2750End Page: 2770Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1080/15548627.2025.2531025Best OA location URL: https://doi.org/10.1080/15548627.2025.2531025Citation Count: 4
-
OPENTitle: Chalcones and Five-Membered Heterocyclic Isosteres Bind to Alpha Synuclein Fibrils in VitroJournal Name: ACS OmegaPublisher: American Chemical Society (ACS)Vol: 3Issue #: 4Start Page: 4486End Page: 4493Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1021/acsomega.7b01897Best OA location URL: https://doi.org/10.1021/acsomega.7b01897Citation Count: 41
-
OPENTitle: Disruption of the LRRK2 substrate RAB12 facilitates neurotransmission and causes hyperactivity in miceJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41531-026-01353-4Best OA location URL: https://doi.org/10.1038/s41531-026-01353-4Citation Count: 0
-
OPENTitle: Network Connectivity Alterations across the MAPT Mutation Clinical SpectrumJournal Name: Annals of NeurologyPublisher: WileyVol: 94Issue #: 4Start Page: 632End Page: 646Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/ana.26738Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ana.26738Citation Count: 7
-
OPENTitle: A sensitive assay reveals structural requirements for α-synuclein fibril growthJournal Name: Journal of Biological ChemistryPublisher: Elsevier BVVol: 292Issue #: 22Start Page: 9034End Page: 9050Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1074/jbc.m116.767053Best OA location URL: http://www.jbc.org/article/S0021925820427061/pdfCitation Count: 30
-
OPENTitle: USP 14 inhibition corrects an in vivo model of impaired mitophagyJournal Name: EMBO Molecular MedicinePublisher: Springer Science and Business Media LLCVol: 10Issue #: 11Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.15252/emmm.201809014Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.15252/emmm.201809014Citation Count: 117
- Lack of independent mood-enhancing effect for dopaminergic medications in early Parkinson's disease2019OPENTitle: Lack of independent mood-enhancing effect for dopaminergic medications in early Parkinson's diseaseJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 402Issue #:Start Page: 81End Page: 85Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jns.2019.05.009Best OA location URL: https://zenodo.org/record/3873416Citation Count: 6
-
OPENTitle: Persistent activation of the D1R/Shp-2/Erk1/2 pathway in l-DOPA-induced dyskinesia in the 6-hydroxy-dopamine rat model of Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 54Issue #:Start Page: 339End Page: 348Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2013.01.005Best OA location URL: https://doaj.org/article/3a6e644df03c4d82b68e076041de91dcCitation Count: 41
-
RESTRICTEDTitle: Delayed gastric emptying and enteric nervous system dysfunction in the rotenone model of Parkinson's diseaseJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 218Issue #: 1Start Page: 154End Page: 161Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.expneurol.2009.04.023Best OA location URL: http://doi.org/10.1016/j.expneurol.2009.04.023Citation Count: 163
-
OPENTitle: A cross-sectional exploration of the relationship between Parkinson's disease and peripheral blood immune cells in an ethnically diverse East London populationJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 484Issue #:Start Page: 125785End Page: 125785Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jns.2026.125785Best OA location URL: https://www.jns-journal.com/article/S0022-510X(26)00067-5/pdfCitation Count: 1
-
OPENTitle: CLIPPERS: A Treatable Cause of Spastic AtaxiaJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 5Issue #: 2Start Page: 212End Page: 214Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12602Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12602Citation Count: 2
-
OPENTitle: A Proposed Roadmap for Parkinson’s Disease Proof of Concept Clinical Trials Investigating Compounds Targeting Alpha-SynucleinJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 9Issue #: 1Start Page: 31End Page: 61Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-181471Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd181471?id=journal-of-parkinsons-disease%2Fjpd181471Citation Count: 57
- Defining the causes of sporadic Parkinson’s disease in the global Parkinson’s genetics program (GP2)2023OPENTitle: Defining the causes of sporadic Parkinson’s disease in the global Parkinson’s genetics program (GP2)Journal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page: 131End Page: 131Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-023-00533-wBest OA location URL: https://www.nature.com/articles/s41531-023-00533-w.pdfCitation Count: 35
-
OPENTitle: Comprehensive characterization and optimization of anti-LRRK2 (leucine-rich repeat kinase 2) monoclonal antibodiesJournal Name: Biochemical JournalPublisher: Portland Press Ltd.Vol: 453Issue #: 1Start Page: 101End Page: 113Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1042/bj20121742Best OA location URL: https://portlandpress.com/biochemj/article-pdf/453/1/101/675176/bj4530101.pdfCitation Count: 95
-
OPENTitle: The Michael J. Fox Foundation's quest for a cure for Parkinson's disease: an interview with Nicole PolinskiJournal Name: Disease Models & MechanismsPublisher: The Company of BiologistsVol: 16Issue #: 12Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1242/dmm.050605Best OA location URL: https://journals.biologists.com/dmm/article-pdf/16/12/dmm050605/3311458/dmm050605.pdfCitation Count: 0
-
OPENTitle: Deciphering the LRRK code: LRRK1 and LRRK2 phosphorylate distinct Rab proteins and are regulated by diverse mechanismsJournal Name: Biochemical JournalPublisher: Portland Press Ltd.Vol: 478Issue #: 3Start Page: 553End Page: 578Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1042/bcj20200937Best OA location URL: https://portlandpress.com/biochemj/article-pdf/478/3/553/904049/bcj-2020-0937.pdfCitation Count: 52
-
OPENTitle: A Call to Action: Promoting Diversity, Equity, and Inclusion in Parkinson’s Research and CareJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 11Issue #: 3Start Page: 905End Page: 908Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-212593Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd212593?id=journal-of-parkinsons-disease%2Fjpd212593Citation Count: 26
-
OPENTitle: Systematic proteomic analysis of LRRK2-mediated Rab GTPase phosphorylation establishes a connection to ciliogenesisJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 6Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.7554/elife.31012Best OA location URL: https://doi.org/10.7554/elife.31012Citation Count: 504
-
OPENTitle: Screening peripheral biopsies for alpha‐synuclein pathology using deep machine learningJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 16Issue #: S5Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/alz.047358Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.047358Citation Count: 0
- Qualitative Imaging of Adeno-Associated Virus Serotype 2–Human Aromatic L-Amino Acid Decarboxylase Gene Therapy in a Phase I Study for the Treatment of Parkinson Disease2010RESTRICTEDTitle: Qualitative Imaging of Adeno-Associated Virus Serotype 2–Human Aromatic L-Amino Acid Decarboxylase Gene Therapy in a Phase I Study for the Treatment of Parkinson DiseaseJournal Name: NeurosurgeryPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 67Issue #: 5Start Page: 1377End Page: 1385Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1227/neu.0b013e3181f53a5cCitation Count: 71
-
OPENTitle: Cognition among individuals along a spectrum of increased risk for Parkinson’s diseaseJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 13Issue #: 8Start Page: e0201964End Page: e0201964Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0201964Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0201964&type=printableCitation Count: 45
-
OPENTitle: Parkinson’s Progression Markers Initiative: A Milestone-Based Strategy to Monitor Parkinson’s Disease ProgressionJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 13Issue #: 6Start Page: 899End Page: 916Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3233/jpd-223433Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd223433?id=journal-of-parkinsons-disease%2Fjpd223433Citation Count: 64
- Validation of Serum Neurofilament Light Chain as a Biomarker of Parkinson's Disease Progression2020OPENTitle: Validation of Serum Neurofilament Light Chain as a Biomarker of Parkinson's Disease ProgressionJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 11Start Page: 1999End Page: 2008Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28206Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28206Citation Count: 198